News

cardiomems, st. jude medical, heart failure

Important new data presented during the Heart Rhythm Society's (HRS) 36th annual Scientific Session supporting improved outcomes and cost-effectiveness of the CardioMEMS HF System for the...

Big data in cardiology, social media big data analytics, data mining

The buzz term “big data” has made a rapid entry onto the healthcare scene in the past couple years with promises of improving healthcare, but there are still many who are trying to figure out how...

heart regeneration, zebrafish, epicardium, Duke, Poss

While the human heart can’t heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers have discovered properties of a mysterious outer layer of the...

gene therapy, stem cells, heart failure, mutations, Mount Sinai, Hajjar

Gene therapy can clip out genetic material linked to heart failure and replace it with normal genes, according to a study from the Cardiovascular Research Center at Icahn School of Medicine at...

transmyocardial laser revascularization

Transmyocardial laser revascularization (TMLR or TMR) was introduced in the late 1990s as a method to offer relief to patients with incapacitating angina that were poor candidates for other...

Biotronik, CLS, Itrevia, CRT-D, heart failure

Biotronik announced that a unique physiologic sensor is now available in the latest family of cardiac resynchronization therapy defibrillator (CRT-D) devices. Closed Loop Stimulation (CLS) is the...

Thoratec, HeartMate II, ROADMAP

Thoratec Corp. announced results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients...

Sunshine Heart, C-Pulse, COUNTER HF, FDA, review, pause, enrollment

Sunshine Heart Inc. announced that the U.S. Food and Drug Administration (FDA) has reviewed the company’s submission regarding the pause of the COUNTER HF U.S. pivotal study. The FDA has requested...

Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the American College of Cardiology (ACC) 2015...

Biotronik, DX, ICD, Inventra, Itrevia, FDA, ultra-high energy

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its DX line of implantable cardioverter defibrillators (ICDs) that can deliver ultra-high energy on the first...

Philips introduced CareSage at HIMSS 2015, which is new predictive analytics engine that enables health systems to better monitor and care for elderly patients by combining actionable insights...

Penn Medicine, congestive heart failure, readmissions, Health Recovery Solutions

Penn Medicine’s Penn Care at Home program reported a 53 percent reduction in 30-day readmission rates for 130 congestive heart failure patients since implementing software from Health Recovery...

EBR Systems Inc. announced it has raised $20 million for clinical studies and regulatory filings, including commitments toward a second quarter closing. EBR Systems is using the funds to build on...

Cerner, Qualcomm, home health monitoring, 2net, CareAware, EHR

Cerner Corp. and Qualcomm Life Inc. announced an agreement to extend Cerner’s medical device connectivity capabilities beyond the hospital to the home. Cerner will leverage Qualcomm Life’s U.S....

ivabradine (Corlanor)

The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.

CareDx Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high-value, non-invasive surveillance solutions for transplant...

PatientPoint announced that PatientPoint Outreach 3.2 is now certified for Meaningful Use in an ambulatory setting. The software is also compliant with the Office of the National Coordinator (ONC...

SynCardia, Total Artificial Heart, 50cc, FDA, investigational study

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia...

catheter ablation, Afib, Amiodarone, Luigi Di Biase, ACC, heart failure

Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a heart rhythm-regulating drug,...

Bendavia, heart attack, scarring, angioplasty, ACC, study

Patients who received the new drug Bendavia before undergoing angioplasty or stent implantation after a heart attack showed no significant reduction in scarring compared to patients given a...